These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
275 related items for PubMed ID: 25408104
1. Apparent diffusion coefficient ratio correlates significantly with prostate cancer gleason score at final pathology. Boesen L, Chabanova E, Løgager V, Balslev I, Thomsen HS. J Magn Reson Imaging; 2015 Aug; 42(2):446-53. PubMed ID: 25408104 [Abstract] [Full Text] [Related]
2. Apparent Diffusion Coefficient (ADC) Ratio Versus Conventional ADC for Detecting Clinically Significant Prostate Cancer With 3-T MRI. Bajgiran AM, Mirak SA, Sung K, Sisk AE, Reiter RE, Raman SS. AJR Am J Roentgenol; 2019 Sep; 213(3):W134-W142. PubMed ID: 31216201 [Abstract] [Full Text] [Related]
3. Multiparametric MRI in detection and staging of prostate cancer. Boesen L. Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066 [Abstract] [Full Text] [Related]
4. Quantitative evaluation of the relative apparent diffusion coefficient values on multiparametric magnetic resonance imaging to predict higher Gleason score prostate cancer. Kato S, Kamijima S, Inaoka T, Kamiya N, Sasai D, Terada H, Hiruta N, Suzuki H. Scand J Urol; 2018 Jun; 52(3):180-185. PubMed ID: 29939084 [Abstract] [Full Text] [Related]
5. Apparent diffusion coefficient for prostate cancer imaging: impact of B values. Peng Y, Jiang Y, Antic T, Sethi I, Schmid-Tannwald C, Eggener S, Oto A. AJR Am J Roentgenol; 2014 Mar; 202(3):W247-53. PubMed ID: 24555621 [Abstract] [Full Text] [Related]
6. Non-Gaussian water diffusion kurtosis imaging of prostate cancer. Suo S, Chen X, Wu L, Zhang X, Yao Q, Fan Y, Wang H, Xu J. Magn Reson Imaging; 2014 Jun; 32(5):421-7. PubMed ID: 24602826 [Abstract] [Full Text] [Related]
7. Diffusion-weighted MRI as a predictor of extracapsular extension in prostate cancer. Kim CK, Park SY, Park JJ, Park BK. AJR Am J Roentgenol; 2014 Mar; 202(3):W270-6. PubMed ID: 24555624 [Abstract] [Full Text] [Related]
9. Utility of diffusional kurtosis imaging as a marker of adverse pathologic outcomes among prostate cancer active surveillance candidates undergoing radical prostatectomy. Rosenkrantz AB, Prabhu V, Sigmund EE, Babb JS, Deng FM, Taneja SS. AJR Am J Roentgenol; 2013 Oct; 201(4):840-6. PubMed ID: 24059373 [Abstract] [Full Text] [Related]
10. Apparent Diffusion Coefficient Values of the Benign Central Zone of the Prostate: Comparison With Low- and High-Grade Prostate Cancer. Gupta RT, Kauffman CR, Garcia-Reyes K, Palmeri ML, Madden JF, Polascik TJ, Rosenkrantz AB. AJR Am J Roentgenol; 2015 Aug; 205(2):331-6. PubMed ID: 26204283 [Abstract] [Full Text] [Related]
11. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer. Roethke MC, Kuder TA, Kuru TH, Fenchel M, Hadaschik BA, Laun FB, Schlemmer HP, Stieltjes B. Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657 [Abstract] [Full Text] [Related]
12. Preoperative Evaluation of Prostate Cancer Aggressiveness: Using ADC and ADC Ratio in Determining Gleason Score. Woo S, Kim SY, Cho JY, Kim SH. AJR Am J Roentgenol; 2016 Jul; 207(1):114-20. PubMed ID: 27077643 [Abstract] [Full Text] [Related]
13. Correlation of ADC and T2 measurements with cell density in prostate cancer at 3.0 Tesla. Gibbs P, Liney GP, Pickles MD, Zelhof B, Rodrigues G, Turnbull LW. Invest Radiol; 2009 Sep; 44(9):572-6. PubMed ID: 19692841 [Abstract] [Full Text] [Related]
14. Clinical utility of apparent diffusion coefficient (ADC) values in patients with prostate cancer: can ADC values contribute to assess the aggressiveness of prostate cancer? Itou Y, Nakanishi K, Narumi Y, Nishizawa Y, Tsukuma H. J Magn Reson Imaging; 2011 Jan; 33(1):167-72. PubMed ID: 21182135 [Abstract] [Full Text] [Related]
15. Multiparametric magnetic resonance imaging for the assessment of extracapsular invasion and other staging parameters in patients with prostate cancer candidates for radical prostatectomy. Lista F, Gimbernat H, Cáceres F, Rodríguez-Barbero JM, Castillo E, Angulo JC. Actas Urol Esp; 2014 Jun; 38(5):290-7. PubMed ID: 24387827 [Abstract] [Full Text] [Related]
16. Clinical utility of apparent diffusion coefficient values obtained using high b-value when diagnosing prostate cancer using 3 tesla MRI: comparison between ultra-high b-value (2000 s/mm²) and standard high b-value (1000 s/mm²). Kitajima K, Takahashi S, Ueno Y, Yoshikawa T, Ohno Y, Obara M, Miyake H, Fujisawa M, Sugimura K. J Magn Reson Imaging; 2012 Jul; 36(1):198-205. PubMed ID: 22371381 [Abstract] [Full Text] [Related]
17. Does normalisation improve the diagnostic performance of apparent diffusion coefficient values for prostate cancer assessment? A blinded independent-observer evaluation. Rosenkrantz AB, Khalef V, Xu W, Babb JS, Taneja SS, Doshi AM. Clin Radiol; 2015 Sep; 70(9):1032-7. PubMed ID: 26126712 [Abstract] [Full Text] [Related]
18. Differentiation of central gland prostate cancer from benign prostatic hyperplasia using monoexponential and biexponential diffusion-weighted imaging. Liu X, Zhou L, Peng W, Wang C, Wang H. Magn Reson Imaging; 2013 Oct; 31(8):1318-24. PubMed ID: 23791546 [Abstract] [Full Text] [Related]
19. Transition zone prostate cancer: detection and localization with 3-T multiparametric MR imaging. Hoeks CM, Hambrock T, Yakar D, Hulsbergen-van de Kaa CA, Feuth T, Witjes JA, Fütterer JJ, Barentsz JO. Radiology; 2013 Jan; 266(1):207-17. PubMed ID: 23143029 [Abstract] [Full Text] [Related]
20. Prostate cancer aggressiveness: assessment with whole-lesion histogram analysis of the apparent diffusion coefficient. Donati OF, Mazaheri Y, Afaq A, Vargas HA, Zheng J, Moskowitz CS, Hricak H, Akin O. Radiology; 2014 Apr; 271(1):143-52. PubMed ID: 24475824 [Abstract] [Full Text] [Related] Page: [Next] [New Search]